Abstract: The invention relates to an apparatus and method for tracking energy consumption. An energy tracking system comprises at least one switching element, at least one inductor and a control block to keep the output voltage at a pre-selected level. The switching elements are configured to apply the source of energy to the inductors. The control block compares the output voltage of the energy tracking system to a reference value and controls the switching of the switched elements in order to transfer energy for the primary voltage into a secondary voltage at the output of the energy tracking system. The electronic device further comprises an ON-time and OFF-time generator and an accumulator wherein the control block is coupled to receive a signal from the ON-time and OFF-time generator and generates switching signals for the at least one switching element in the form of ON-time pulses with a constant width ON-time.

Abstract: The invention relates to an apparatus and method for tracking energy consumption. An energy tracking system comprises at least one switching element, at least one inductor and a control block to keep the output voltage at a pre-selected level. The switching elements are configured to apply the source of energy to the inductors. The control block compares the output voltage of the energy tracking system to a reference value and controls the switching of the switched elements in order to transfer energy for the primary voltage into a secondary voltage at the output of the energy tracking system. The electronic device further comprises an ON-time and OFF-time generator and an accumulator wherein the control block is coupled to receive a signal from the ON-time and OFF-time generator and generates switching signals for the at least one switching element in the form of ON-time pulses with a constant ON-time.

Abstract: The present invention relates to compounds useful as inhibitors of indoleamine 2,3-dioxygenase (IDO). The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications. The compounds of this invention have formula I-A: wherein the variables are as defined herein.

Abstract: An organic electroluminescent device comprising: a pair of electrodes comprising an anode and a cathode, and one or more layers of organic compound arranged between the pair of electrodes, wherein the organic compound layer, or one or more of the organic compound layers, comprises a compound represented by a substituted imidazole. The substituents on the imidazole ring may be selected from a range of suitable substituents, including: substituted or unsubstituted aryl groups, substituted or unsubstituted heterocyclic groups, substituted or unsubstituted alkyl groups or cyano groups. In various aspects of the invention, at least one of the substituent groups may be a substituted or unsubstituted imidazole or thiophene group.

Abstract: The invention relates to an electronic device comprising a switched mode power converter comprising a switched transistor, an inductor and an error amplifier. The switched transistor is configured to switch a current through the inductor. The error amplifier is configured to control the switching of the switched transistor to convert a primary voltage applied at the input into a secondary voltage at the output of the switched mode power converter. The electronic device further comprises an oscillator, a control logic stage and a digital counter. The control logic stage is coupled to receive a clock signal from the oscillator and to generate switching signals for the switched transistor in form of ON-time pulses with a constant ON-time according to a pulse density scheme. The counter is configured to count the number of ON-time pulses for determining the consumed power based on the number of ON-time pulses per time.

Abstract: The invention relates to a filter cartridge (1) which comprises a firmly fixed lid (10) and has a long service life. Said lid (10) is embodied in such a way that the bottom (11) of the lid extends towards the peripheral wall (3) of the cartridge container to join the lateral wall (16) of the lid, by means of an inwardly curved edge section (14), the curved edge section (14) and the lateral wall (16) in the form of a strip joining in the forming region to form an inwardly tapered common wall section (15). In this way, the region fixing the lateral wall (16) to the peripheral wall (3) is subjected only to a tensile load, minimizing the risk of shear fracture, and the inner pressure in the region of the common wall section (15) presses the wall section against the peripheral wall (3), thus exerting an additional sealing force.

Abstract: An organic electroluminescent device comprising: a pair of electrodes comprising an anode and a cathode, and one or more layers arranged between the anode and the cathode; wherein at least one of the one or more layers is a light emitting layer and wherein the one or more layers, comprises an organic compound represented by a substituted 2,2?-biimidazole.

Abstract: The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.

Abstract: A pumping unit having a pump chamber with a rotor mounted in a rotatable manner within the chamber. The pumping chamber is formed by a circumferential wall and two end walls. The circumferential wall is formed on an annular collar of a pump part and has on its inner surface a track on which sealing bodies of a rotor roll. To avoid deformation of the pump part by hydraulic forces or by pressing-in forces, ribs are arranged on the outer surface of the circumferential wall which extend away from the pump chamber. A shoulder is arranged on the side of the end wall which is directed away from the pump chamber. The shoulder is connected by a press fit to the pump housing and has thin walls so that pressing forces do not result in any deformation to the end wall of the pump chamber.

Abstract: A medical system includes a carrier and a multiplicity of electromechanical transducers mounted to the carrier, the transducers being disposable in effective pressure-wave-transmitting contact with a patient. Energization componentry is operatively connected to a first plurality of the transducers for supplying the same with electrical signals of at least one pre-established ultrasonic frequency to produce first pressure waves in the patient. A control unit is operatively connected to the energization componentry and includes an electronic analyzer operatively connected to a second plurality of the transducers for performing electronic 3D volumetric data acquisition and imaging (which includes determining three-dimensional shapes) of internal tissue structures of the patient by analyzing signals generated by the second plurality of the transducers in response to second pressure waves produced at the internal tissue structures in response to the first pressure waves.

Abstract: Devices, systems, methods, and other embodiments associated with a network device for interfacing a host with a network are described. One example network device includes a transmit path, and a receive path. A loopback path connects the transmit path and the receive path. A frame detection logic is configured to monitor network traffic on the transmit path to identify loopback frames. When a loopback frame is detected, a loopback logic routes the identified loopback frame onto the loopback path and then to the receive path. The rerouted loopback frame may then be received by a host or an embedded client from the receive path.

Abstract: For safe storage and simple and safe administration of tablets T by a user, a cartridge 900 is provided that can be inserted into a medicament dispenser 1 for solid medicament portions T and that is designed with a reservoir for receiving the medicament portions T, and a medicament dispenser 1 for this cartridge 900 is also provided. According to the invention, the cartridge 900 comprises a singulation device 910 that is designed to dispense defined medicament portions T and that comprises a movable mechanism 940 for separating a defined medicament portion T from the reservoir and for dispensing it from the medicament dispenser 1, wherein the singulation device 910 is designed to produce an operative connection to an actuating device 14, 220, 224, 226; 15, 210; 230 in the medicament dispenser 1.

Abstract: The present invention provides crystalline molecules or molecular complexes which comprise binding pockets of Aurora-2 or its homologues. The invention also provides crystals comprising Aurora-2. The present invention also relates to a computer comprising a data storage medium encoded with the structural coordinates of Aurora-2 binding pockets and methods of using a computer to evaluate the ability of a compound to bind to the molecule or molecular complex. This invention also provides methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention provides methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to Aurora-2 or homologues thereof.

Abstract: The invention relates to a shaping tool which is used to shape a workpiece, in particular, a sheet steel component, comprising at least two shaping tool halves. Contoured regions are provided in the region of the shaping tool halves in order to give the workpiece a corresponding contour, at least in sections. Each shaping tool half has a shaping surface shell which is oriented towards the workpiece and a support shaping half. The shaping surface shell is arranged on the support shaping half and comprises a shaping surface, which is oriented towards the workpiece, and a rear side which is oriented away from the workpiece. The support shaping half comprises a contoured area which essentially corresponds to the contour of the workpiece which is to be produced and the contoured area is surrounded by a flange area. Grooves are provided in the contoured area in the region of the rear side of the shaping surface shell.

Abstract: A plant for the heat treatment of solids containing iron oxide includes a fluidized bed reactor. The reactor includes at least one gas supply tube at least partly surrounded by an annular chamber in which a stationary annular fluidized bed is located, and a mixing chamber being located above the upper orifice region of the at least one gas supply tube. The gas flowing through the at least one gas supply tube entrains solids from the stationary annular fluidized bed-into the mixing chamber when passing through the upper orifice region of the at least one gas supply tube.

Abstract: A plant for the heat treatment of solids containing iron oxide. The plant includes a reactor including a fluidized bed reactor. The reactor includes a gas supply system disposed in the reactor, a stationary annular fluidized bed which at least partly surrounds the gas supply system, and a mixing chamber. The gas supply system is configured so that gas flowing through the gas supply system entrains solids from the stationary annular fluidized bed into the mixing chamber.

Abstract: The present invention relates to methods for identifying compounds useful for regulating TNF-alpha levels and/or activity. The invention also relates to methods for decreasing TNF-alpha levels and/or activity. Compounds and compositions according to this invention are useful for treating TNF-mediated diseases. The invention also relates to kits comprising the compounds and compositions herein and a tool for measuring TNF-alpha activity and/or levels.